Novo Nordisk announces positive phase 2 trial results for type 2 ...
WEBAug 23, 2022 · Commenting on the positive results, Martin Holst Lange, executive vice president for development at Novo Nordisk, said: “We are encouraged by the impressive phase 2 results for CagriSema in people with type 2 diabetes. The results indicate that CagriSema reduces blood sugar more than semaglutide alone and …
Communique - PMLiVE
WEBCommuniqué – Volume 53. New insights in health comms innovation. Communiqué Awards 2022 – winners’ case studies. INSIGHTS – Demonstrating impact • Driving behaviour change.
About T40 - PMLiVE
WEBThe aim of the T40 listing is to highlight those creative agencies having the most impact in the UK healthcare sector in 2022. The agencies were drawn from a shortlist based on selected 2022 healthcare awards schemes and specialist advertising, branding, creative and design agencies drawn from a number of sources including PMLiVE’s PMHub ...
Bad news for Innate Pharma as BMS-backed drug stumbles
WEBNov 23, 2017 · French biotech Innate Pharma says it can’t see a development path forward for its lead cancer drug lirilumab after another clinical trial miss. The Bristol-Myers Squibb-partnered checkpoint inhibitor, licensed in a $465m deal in 2011, said that the combination of lirilumab and BMS’ PD-1 inhibitor Opdivo (nivolumab) failed to show any ...
News: Living with Ulcerative Colitis and Crohn’s Disease
WEBJul 17, 2020 · Living with Ulcerative Colitis (UC) and Crohn’s Disease (CD) are new patient syndicated reports which offer valuable insights into patient attitudes and behaviour towards their condition, treatments and unmet needs. These reports provide pharmaceutical companies with a strong, foundational knowledge and …
Login - PMLiVE
WEBResults from Global Pharmaceutical Customer Experience survey; Strategy execution – ensuring it all fits together ‘Causes That Count, Health’ report – key issues affecting global health
Pfizer helps fund biotech venture from former researchers at …
WEBNov 5, 2012 · Pfizer is to help fund research by Ziarco, a recently launch UK biotech headed by a scientist formerly at Pfizer’s research centre in Kent, UK. Ziarco’s CEO Dr Mike Yeadon was chief scientific officer, allergy and respiratory research, during his time at Pfizer, before the US pharma firm announced last year it would leave the facility.
Novartis sues US government over Medicare drug price ... - PMLiVE
WEBSep 5, 2023 · Novartis has become the latest drugmaker to sue the US government over the Medicare drug price negotiation element of President Biden’s Inflation Reduction Act (IRA). The lawsuit, filed in federal court in New Jersey, comes just days after the Centers for Medicare and Medicaid Services (CMS) announced the first ten prescription drugs that ...
This month in 1917: A tale of two Mercks - PMLiVE
WEBApr 14, 2014 · But on April 6, 1917 – influenced by the Germans’ use of unrestricted submarine warfare – President Woodrow Wilson declared the country’s formal participation on the side of the Allies. With this declaration the US Government also announced the seizure of several companies with German connections, including Merck & Co.
Realising the potential of omnichannel in medical communications
WEBJun 6, 2022 · More specifically, omnichannel means that Medical Affairs teams can align the scientific narrative to a specific point in their audience relationship. They can educate HCPs from being aware of particular therapies, to being able to trust and consider them at the time of clinical need. Traditional Medical Affairs activities generally focused on ...